全文获取类型
收费全文 | 4537篇 |
免费 | 278篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 152篇 |
妇产科学 | 49篇 |
基础医学 | 618篇 |
口腔科学 | 100篇 |
临床医学 | 323篇 |
内科学 | 1035篇 |
皮肤病学 | 217篇 |
神经病学 | 291篇 |
特种医学 | 118篇 |
外科学 | 526篇 |
综合类 | 39篇 |
预防医学 | 213篇 |
眼科学 | 186篇 |
药学 | 336篇 |
中国医学 | 19篇 |
肿瘤学 | 562篇 |
出版年
2024年 | 6篇 |
2023年 | 52篇 |
2022年 | 90篇 |
2021年 | 135篇 |
2020年 | 66篇 |
2019年 | 100篇 |
2018年 | 163篇 |
2017年 | 117篇 |
2016年 | 117篇 |
2015年 | 109篇 |
2014年 | 165篇 |
2013年 | 175篇 |
2012年 | 329篇 |
2011年 | 319篇 |
2010年 | 219篇 |
2009年 | 174篇 |
2008年 | 255篇 |
2007年 | 277篇 |
2006年 | 294篇 |
2005年 | 248篇 |
2004年 | 238篇 |
2003年 | 231篇 |
2002年 | 223篇 |
2001年 | 64篇 |
2000年 | 75篇 |
1999年 | 82篇 |
1998年 | 42篇 |
1997年 | 39篇 |
1996年 | 30篇 |
1995年 | 30篇 |
1994年 | 23篇 |
1993年 | 14篇 |
1992年 | 32篇 |
1991年 | 36篇 |
1990年 | 26篇 |
1989年 | 36篇 |
1988年 | 33篇 |
1987年 | 29篇 |
1986年 | 25篇 |
1985年 | 29篇 |
1984年 | 14篇 |
1983年 | 13篇 |
1982年 | 13篇 |
1981年 | 4篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1974年 | 2篇 |
1968年 | 6篇 |
1967年 | 4篇 |
1966年 | 7篇 |
排序方式: 共有4838条查询结果,搜索用时 15 毫秒
101.
Nobuaki Hoshino Suguru Hasegawa Koya Hida Kenji Kawada Kenichi Sugihara Yoshiharu Sakai 《International journal of colorectal disease》2016,31(7):1307-1313
Purpose
A small number of lymph nodes retrieved (NLNR) is a known risk factor in stage II colorectal cancer. NLNR is influenced by age, but little is known about whether the impact of small NLNR on survival differs with age. This retrospective study sought to determine such impact in elderly patients with stage II colorectal cancer.Methods
We reviewed data for 2100 patients with stage II colorectal cancer who underwent surgery without adjuvant chemotherapy between January 1997 and December 2003. The optimal cutoff value of NLNR for survival was determined, and the impact of small NLNR on survival was analyzed. The association between age and NLNR was evaluated. The relation between age and risk of small NLNR with respect to survival was then assessed to determine the impact of small NLNR on elderly patients’ survival.Results
The optimal cutoff value of NLNR was determined as 6. The small NLNR group (SNG) showed significantly worse prognosis than the large NLNR group (LNG) (p?<?0.001). Age, surgical method, and scope of lymph node dissection were significantly associated with NLNR. A potential interaction was noted between age and risk of small NLNR in relation to relapse-free survival (RFS). Five-year RFS was significantly worse in SNG than in LNG for elderly patients (41.7 and 76.4 %, respectively; p?<?0.001) but not for non-elderly patients (75.9 and 84.6 %, respectively; p?=?0.083).Conclusions
NLNR <6 was identified to be an important prognostic factor for elderly patients with stage II colorectal cancer.102.
Breathing 30 per cent oxygen attenuates bronchial responsiveness to methacholine in asthmatic patients 总被引:2,自引:0,他引:2
H Inoue C Inoue M Okayama K Sekizawa W Hida T Takishima 《The European respiratory journal》1989,2(6):506-512
The effect of breathing 30% oxygen on bronchial responsiveness to inhaled methacholine was studied in 30 asthmatic patients using a direct graphical recording method. An aerosol of methacholine solution was inhaled during tidal breathing by measuring respiratory resistance (Rrs) continuously, and dose-response curves were obtained on two separate days during air and 30% oxygen inhalation. Oxygen inhalations for 20 min caused no change in baseline Rrs. The threshold dose of methacholine, the dose which increased Rrs from the baseline value while breathing 30% oxygen, increased significantly compared with that while breathing air (p less than 0.01). No significant difference was found between the mean values of the slopes of the dose-response curves of the two groups. End-expiratory oxygen concentration (FETO2) during air breathing decreased significantly from 13.7% to 12.0% at the point where methacholine dosage reached threshold. This study suggests that hyperoxia attenuates the bronchial responsiveness to methacholine in asthmatic patients. 相似文献
103.
Harada-Shiba M Takagi A Marutsuka K Moriguchi S Yagyu H Ishibashi S Asada Y Yokoyama S 《Circulation research》2004,95(9):945-952
We previously characterized the patients with autosomal recessive hypercholesterolemia (ARH) as having severe hypercholesterolemia and retarded plasma low-density lipoprotein (LDL) clearance despite normal LDL receptor (LDLR) function in their cultured fibroblasts, and we identified a mutation in the ARH locus in these patients. ARH protein is an adaptor protein of the LDL and reportedly modulates its internalization. We developed ARH knockout mice (ARH-/-) to study the function of this protein. Plasma total cholesterol level was higher in ARH-/- mice than that in wild-type mice (ARH+/+), being attributed to a 6-fold increase of LDL, whereas plasma lipoprotein was normal in the heterozygotes (ARH+/-). Clearance of 125I-LDL from plasma was retarded in ARH-/- mice, as much as that found in LDLR-/- mice. Fluorescence activity of the intravenously injected 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI)-LDL was recovered in the cytosol of the hepatocytes of ARH+/+ mice, but not in those of ARH-/- or LDLR-/- mice. Also, less radioactivity was recovered in the liver of ARH-/- or LDLR-/- mice when [3H]cholesteryl oleyl ether (CE)-labeled LDL was injected. In contrast, uptakes of [3H]CE-labeled LDL, 125I-LDL, and DiI-LDL were all normal or slightly subnormal when the ARH-/- hepatocytes were cultured. We thus concluded that the function of the hepatic LDLR is impaired in the ARH-/- mice in vivo, despite its normal function in vitro. These findings were consistent with the observations with the ARH homozygous patients and suggested that certain cellular environmental factors modulate the requirement of ARH for the LDLR function. 相似文献
104.
Kenya Nasu Etsuo Tsuchikane Osamu Katoh D Geoffrey Vince Renu Virmani Jean-Fran?ois Surmely Akira Murata Yoshihiro Takeda Tatsuya Ito Mariko Ehara Tetsuo Matsubara Mitsuyasu Terashima Takahiko Suzuki 《Journal of the American College of Cardiology》2006,47(12):2405-2412
OBJECTIVES: The goal of the present study was to compare the accuracy of in vivo tissue characterization obtained by intravascular ultrasound (IVUS) radiofrequency (RF) data analysis, known as Virtual Histology (VH), to the in vitro histopathology of coronary atherosclerotic plaques obtained by directional coronary atherectomy. BACKGROUND: Vulnerable plaque leading to acute coronary syndrome (ACS) has been associated with specific plaque composition, and its characterization is an important clinical focus. METHODS: Virtual histology IVUS images were performed before and after a single debulking cut using directional coronary atherectomy. Debulking region of in vivo histology image was predicted by comparing pre- and post-debulking VH images. Analysis of VH images with the corresponding tissue cross section was performed. RESULTS: Fifteen stable angina pectoris (AP) and 15 ACS patients were enrolled. The results of IVUS RF data analysis correlated well with histopathologic examination (predictive accuracy from all patients data: 87.1% for fibrous, 87.1% for fibro-fatty, 88.3% for necrotic core, and 96.5% for dense calcium regions, respectively). In addition, the frequency of necrotic core was significantly higher in the ACS group than in the stable AP group (in vitro histopathology: 22.6% vs. 12.6%, p = 0.02; in vivo virtual histology: 24.5% vs. 10.4%, p = 0.002). CONCLUSIONS: Correlation of in vivo IVUS RF data analysis with histopathology shows a high accuracy. In vivo IVUS RF data analysis is a useful modality for the classification of different types of coronary components, and may play an important role in the detection of vulnerable plaque. 相似文献
105.
Matsuyama S Shimonishi T Yoshimura H Higaki K Nasu K Toyooka M Aoki S Watanabe K Sugihara H 《World journal of gastroenterology : WJG》2008,14(18):2924-2927
A 79-year-old man was referred to this department due to the presence of extrahepatic bile duct carcinoma with a tumor at the left chest wall. The lesion was suspected to be a metastasis of bile duct carcinoma to the left wall, however, computed tomography (CT) revealed no regional lymph node or liver metastases. In addition, cytological and pathological examinations did not show malignancy. At the time of admission, the white blood cell count was 21 460 cells/μL (neutrophils, 18 240 cells/μL) and this elevated to 106 040 before death. In addition, serum granulocyte colony-stimulating factor (G-CSF) was elevated. At 28 d after admission, the patient died. An autopsy showed a poorly differentiated adenocarcinoma with sarcomatous change, which had slightly invaded into the pancreas around the bile duct, and was found in the distal bile duct with multiple metastases to the chest wall, lung, kidney, adrenal body, liver, mesentery, vertebra and mediastinal and para-aortic lymph nodes, without locoregional lymph node and liver metastasis. The cancer cells showed positive immunohistochemical staining for anti-G-CSF antibody. This is believed to be the first report of an extrahepatic bile duct carcinoma that produces G-CSF. Since G-CSF-producing carcinoma and sarcomatous change of the biliary tract leads to poor prognosis, early diagnosis and treatment are needed. When infection is ruled out, the G-CSF in serum should be examined. In addition, examinations such as bonescintigraphy and chest CT should also be considered for distant metastasis. 相似文献
106.
Yasuji Arase M.D. Hiromitsu Kumada Kazuaki Chayama Akihito Tsubota Kenji Ikeda Satoshi Saitoh Yoko Sakai Toyomi Matsumoto Mariko Kobayashi 《Journal of gastroenterology》1992,27(5):646-651
Interferon (IFN) has been shown to be effective for chronic hepatitis C. This study investigated changes of alanine aminotransferase
(ALT) and HCV-RNA in chronic hepatitis C patients treated withα-IFN. IFN was given to 73 patients with HCV-RNA positive chronic hepatitis C. The pattern of changes in ALT activity after
IFN aministration was classified into five types. Type 1 was characterized by normalization of ALT (≤25 K.U) during IFN administration
and sustained normalization after the IFN therapy. Type 2 involved a rebound of ALT after termination of IFN therapy and subsequent
normalization. Type 3 had no ALT normalization during IFN administration, with normalization after the completion of the therapy.
Type 4 involved transient normalization of ALT level during IFN therapy, with a subsequent reversion to abnormal levels after
the termination of IFN therapy. Type 5 showed sustained abnormally high levels of ALT activity both during and after treatment.
Twenty four patients (32.9%) had sustained normalization ALT (≤25 K.U) after the termination of IFN treatment. The HCV-RNA
negative rate at 6 months after IFN therapy in patients with sustained normalization of ALT was 87.5% (21/24). 相似文献
107.
Natsuko Kobayashi Hiroko Iijima Toshifumi Tada Yoko Shibata Takashi Nishimura Takashi Kumada Mariko Hashimoto Akiko Higashiura Masahiro Yoshida Junko Nishimura Nobuhiro Aizawa Naoto Ikeda Tomoyuki Takashima Ryo Takata Hiroki Nishikawa Yoshinori Iwata Hirayuki Enomoto Seiichi Hirota Etsuro Hatano 《Ultrasound in medicine & biology》2021,47(4):941-946
The aim of the study described here was to clarify the diagnostic value of the fluttering sign, a new sign that characterizes hepatic hemangiomas in gray-scale ultrasonography (US). It refers to a phenomenon in which the speckled echogenicity inside the hemangioma changes continuously and seems to be moving. A total of 172 hemangiomas diagnosed with contrast-enhanced US were evaluated. The fluttering sign was found in 123 of 172 hemangiomas (71.5%). Its prevalence was significantly higher than that of the marginal strong echo (89/172, 51.7%, p < 0.001), posterior acoustic enhancement (103/172, 59.9%, p = 0.031) and chameleon sign (100/172, 58.1%, p = 0.013). In addition, the fluttering sign was observed significantly more frequently in mixed or hypo-echoic tumors than in hyper-echoic tumors (p < 0.001), relatively large tumors (p < 0.001) and tumors that were less than 5 cm from the body surface (p = 0.015). The fluttering sign in gray-scale US has great potential to be a new complementary sign for the diagnosis of hemangioma. 相似文献
108.
109.
Norio Akuta Fumitaka Suzuki Taito Fukushima Yusuke Kawamura Hitomi Sezaki Yoshiyuki Suzuki Tetsuya Hosaka Masahiro Kobayashi Tasuku Hara Mariko Kobayashi Satoshi Saitoh Yasuji Arase Kenji Ikeda Hiromitsu Kumada 《Journal of clinical microbiology》2013,51(9):2862-2868
It is often difficult to predict the response to telaprevir-pegylated interferon (PEG-IFN)-ribavirin triple therapy and the appearance of telaprevir-resistant variants. The present study determined the predictive factors of a sustained virological response (SVR) to 12- or 24-week triple therapy (T12PR12 or T12PR24, respectively) in 194 Japanese patients infected with hepatitis C virus genotype 1b (HCV-1b). The study also evaluated whether ultradeep sequencing technology can predict at baseline the emergence of resistant variants after the start of therapy. Analysis of the data of the entire group indicated that an SVR was achieved in 78% of the patients. Multivariate analysis identified IL28B rs8099917 (genotype TT), the substitution of amino acid (aa) 70 (Arg70), response to prior treatment (naive or relapse), PEG-IFN dose (≥1.3 μg/kg of body weight), and treatment regimen (T12PR24) as significant determinants of SVR. Among patients of the T12PR24 group, 92% with genotype TT achieved an SVR, irrespective of a substitution at aa 70. In patients with the non-TT genotype, an SVR was achieved in 76% of those with Arg70, while only 14% of patients with the non-TT genotype, Gln70(His70), and nonresponse to ribavirin combination therapy achieved an SVR. Ultradeep sequencing was conducted for 17 patients who did not achieve an SVR to determine the emergence of resistant variants during therapy. De novo resistant variants were detected in 16 of 17 patients (94%), regardless of the variant frequencies detected at baseline. In conclusion, the results indicate that the response to triple therapy can be predicted by the combination of host, viral, and treatment factors and that it is difficult to predict at baseline the telaprevir-resistant variants that emerge during triple therapy, even with the use of ultradeep sequencing. 相似文献
110.
Kazuo Kubota Hidenori Ohnishi Takahide Teramoto Eiko Matsui Kana Murase Hiroyuki Kanoh Zenichiro Kato Hideo Kaneko Mariko Seishima Naomi Kondo 《Journal of clinical immunology》2013,33(2):325-334